« Back
Home /
Recombinant Human TRAILR1/DR4

Recombinant Human TRAILR1/DR4

Manufacturer	Cell Sciences
Category	Oncology Neuroscience Neuroinflammation Metabolism Diabetes Peptides & Proteins Recombinant Proteins Cell Biology Obesity Cell Culture Cytokines Cell Status Necrosis Apoptosis Cardiovascular Research Ischemia & Reperfusion Injury
Type	Proteins
Specific against	Human
Format	Lyophilized
Amount	50 ug
Host	E.coli
Item no.	CS-CRT501B
Targets	TNFRSF1A, CD261, TNF
eClass 6.1	34160400
eClass 9.0	42020190
Available
Biological Activity	Determined by its inhibitory effect of IL-8 production in human PBMC by Human sTRAIL/Apo2L. 95% inhibition (100ng/ml of sTRAIL/Apo2L) was reached using a concentration of 1000ng/ml of sTRAIL Receptor-1.
Description	Human sTRAIL Receptor-1, also known as DR4 (Death Receptor-4), is a member of the TNF receptor family. Human sTRAIL Receptor-1 is a 22.7 kDa protein containing 215 amino acid residues comprising the extracellular domain of TRAIL Receptor-1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.